By Hans Sauer, Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization Question from a Reader...

We all heard reports that January was a great start to 2012 for the stock market, and even more so for Biotech. But how big was it...

Biotechnology continues to hold the greatest promise to address many of the most critical issues facing our world. Continued inno...

Q&A with ARPA-E Deputy Director for Commercialization Cheryl Martin Q: What is the mission of ARPA-E, and how do you work t...

By Prarthana Dalal, 2011 International BioGENEius Challenge 1st Place Winner Project Title: Modeling of human non-deletional h...

Fortune magazine’s Marc Gunther wrote a blog this week about the growing adoption of  biotech crops and the debate over their u...

By Marc Boutin, JD, Executive Vice President and Chief Operating Officer, National Health Council At this time of the year, it...